We read with great interest the article 'Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment' recently published by Mito and colleagues (2018). Using the novel technique of fixed-based analysis (FBA) this cross-sectional study confirmed previous findings from in vivo diffusion weighted imaging (DWI)/diffusion tensor imaging (DTI) that indicate degeneration in specific fibre pathways functionally implicated in Alzheimer's disease, as well as new data revealing axonal reduction within the posterior cingulum in patients with mild cognitive impairment (MCI). One of the main aims of the study was to determine a potential association of amyloid-b accumulation with white matter degeneration by comparing measures of white matter tract degeneration between MCI patients with a positive amyloid-b PET scan ( 11 C-PiB), i.e. likely representing prodromal Alzheimer's disease dementia, and those with a negative amyloid-b PET scan. Contrary to the author's expectations, no robust statistical differences relating to degeneration of any white matter tracts and amyloid status were revealed. However, from our point of view this is not surprising as amyloid-b pathology alone does not have an impact on cognitive performance and is not the only neuropathological correlate of Alzheimer's disease since the latter is characterized by the presence of both amyloid-b and hyperphosphorlyated tau (HP) pathology. Hence, we would like to highlight the possible impact of cortical HP pathology on white matter degeneration in the Alzheimer's disease and MCI cohorts investigated by Mito and colleagues (2018).
Sir,
We read with great interest the article 'Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment' recently published by Mito and colleagues (2018) . Using the novel technique of fixed-based analysis (FBA) this cross-sectional study confirmed previous findings from in vivo diffusion weighted imaging (DWI)/diffusion tensor imaging (DTI) that indicate degeneration in specific fibre pathways functionally implicated in Alzheimer's disease, as well as new data revealing axonal reduction within the posterior cingulum in patients with mild cognitive impairment (MCI). One of the main aims of the study was to determine a potential association of amyloid-b accumulation with white matter degeneration by comparing measures of white matter tract degeneration between MCI patients with a positive amyloid-b PET scan ( 11 C-PiB), i.e. likely representing prodromal Alzheimer's disease dementia, and those with a negative amyloid-b PET scan. Contrary to the author's expectations, no robust statistical differences relating to degeneration of any white matter tracts and amyloid status were revealed. However, from our point of view this is not surprising as amyloid-b pathology alone does not have an impact on cognitive performance and is not the only neuropathological correlate of Alzheimer's disease since the latter is characterized by the presence of both amyloid-b and hyperphosphorlyated tau (HP) pathology. Hence, we would like to highlight the possible impact of cortical HP pathology on white matter degeneration in the Alzheimer's disease and MCI cohorts investigated by Mito and colleagues (2018) .
We recently published quantitative neuropathological studies, using human post-mortem tissue that specifically investigated the relationship between parietal white matter degeneration and HP pathology in an Alzheimer's disease and normal aged non-demented cohort (McAleese et al., 2015 . In these studies we reported that (in-line with the development of Alzheimer's disease) increasing cortical HP pathology, and not cerebrovascular or amyloid-b pathology, was significantly associated with, and a predictor of, white matter hyperintensity scores in postmortem MRI of parietal and temporal regions (McAleese et al., 2015) . Subsequently, we found significant differences in the pathological and molecular signatures, and hence the aetiology of parietal white matter damage between Alzheimer's disease and non-demented controls, with white matter damage in Alzheimer's disease being associated with a degenerative loss (i.e. Wallerian degeneration) of axons and associated demyelination as a consequence of increased cortical burden of HP pathology. This is in contrast to white matter damage seen in non-demented individuals that primarily demonstrated demyelination only, which was associated with cerebrovascular small vessel disease (SVD) and markers of hypoxia . These were the first published human neuropathological data to clearly demonstrate differences in the pathological and molecular composition and aetiology of posterior white matter damage, and corroborate data from various neuroimaging studies, inclusive of the study by Mito and colleagues, which demonstrate Alzheimer's disease-specific white matter changes.
The specific white matter tracts exhibiting degeneration identified by Mito and colleagues connect brain regions that have been shown to be functionally implicated in Alzheimer's disease. Furthermore, these tracts are associated with cortical areas affected early in the hierarchal progression of HP pathology: a key example is the parahippocampal gyrus, from which fibre pathways from the posterior cingulum, arcuate fasciculus and inferior fronto-occipital fasciculus connect. As noted by Mito and colleagues, the white matter pathways affected were mostly long association fibres. It has been shown that long (and short) fibres primarily originate from pyramidal cells in layer III and V of the cortex, which constitute the neuronal population selectively affected by HP pathology (Pearson et al., 1985) and as indicated by DTI studies (Bosch et al., 2012; Amlien et al., 2013; Hong et al., 2016) and human post-mortem tissue , Wallerian degeneration can indeed be activated in these pyramidal cell layers and leading to degeneration of the fibre tracts. This notion supports the data from the study by Mito and colleagues as the authors found selective disruption of the posterior cingulum in the amyloid-negative MCI group, which is likely to have considerable HP pathology burden in the hippocampus, parahippocampal gyrus, fusiform gyrus and mid/superior temporal gyrus (i.e. neurofibrillary tangle Braak stage IV) (Braak et al., 2006) . This pattern of HP pathology can cause neuronal and axonal transport dysfunction and initiate a degenerative Wallerian-like mechanism via the activation of protease calpain (Coleman, 2005; Ma et al., 2013) .
Data from human post-mortem studies have shown a strong association of the density and extent of HP pathology with memory deficits (Riley et al., 2002) and overall ante-mortem cognitive decline in Alzheimer's disease (Riley et al., 2002; Giannakopoulos et al., 2003; Walker et al., 2017) . These findings have since been replicated using in vivo -PET radiotracers that confirmed a correlation between 18 F-AV-1451 PET images and Braak stages (Scholl et al., 2016; Schwarz et al., 2016) and more advanced Braak stage-like PET uptake is associated with a decline in global cognitive decline and more frequent cognitive impairment (Cho et al., 2016a; Scholl et al., 2016) . Furthermore, specific cognitive domain performances, such as worse episodic memory and memory decline, are associated with higher 18 F-AV-1451 uptake in the medial temporal region (Scholl et al., 2016) . Importantly, the accumulation of -PET radiotracers is more closely related to functional and structural deterioration in Alzheimer's disease than amyloid-b PET tracers (Cho et al., 2016b) . Therefore, future studies implementing -PET radiotracers rather than amyloid-b PET tracers may offer a better insight into the pathological aetiology of white matter degeneration in vitam.
In summary, the significant white matter loss in Alzheimer's disease and MCI reported by Mito and colleagues is likely to be associated with cortical HP but not with amyloid-b pathology, respectively. These findings further strengthen the argument that white matter hyperintensities on in vivo MRI images of cognitively impaired subjects should not be interpreted as a robust indicator of cerebrovascular disease (vascular dementia) but rather they suggest Alzheimer's disease associated cortical HP pathology.
